SCHEMBL31664575

SCHEMBL31664575

CCCCCCCCCCCCCP(O)(O)(O)CCCCCCCCCCCCC(c1ccccc1)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.49
CSNK1E P49674 1/20 0.45
HTR2A P28223 4/20 0.43
HRH1 P35367 3/20 0.43
NAAA Q02083 2/20 0.41
POLB P06746 1/20 0.41
OPRM1 P35372 1/20 0.41
OPRD1 P41143 1/20 0.41
OPRK1 P41145 1/20 0.41
OPRL1 P41146 1/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
TBXAS1 P24557 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6464144 0.89 CSNK1E (0.44) CSNK1EHTR2ANAAAPOLBOPRM1
SCHEMBL11805794 0.88 SIGMAR1 (0.50) SIGMAR1HTR2AHRH1POLBOPRM1
SCHEMBL15570656 0.87 SIGMAR1 (0.45) SIGMAR1HTR2AHRH1POLBOPRM1
SCHEMBL4740370 0.86 SIGMAR1 (0.62) SIGMAR1CSNK1EHTR2AHRH1NAAA
SCHEMBL9401973 0.86 SIGMAR1 (0.62) SIGMAR1CSNK1EHTR2AHRH1NAAA
SCHEMBL8095418 0.86 SIGMAR1 (0.62) SIGMAR1CSNK1EHTR2AHRH1NAAA
SCHEMBL2863311 0.86 SIGMAR1 (0.62) SIGMAR1CSNK1EHTR2AHRH1NAAA
SCHEMBL8086241 0.86 SIGMAR1 (0.62) SIGMAR1CSNK1EHTR2AHRH1NAAA
SCHEMBL10578613 0.86 SIGMAR1 (0.62) SIGMAR1CSNK1EHTR2AHRH1NAAA
SCHEMBL8100113 0.86 SIGMAR1 (0.62) SIGMAR1CSNK1EHTR2AHRH1NAAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4613784-A1 ESTER COMPOUND-CONTAINING COMPOSITION, METHOD FOR PRODUCING SAME, POLYMERIZABLE COMPOSITION, (METH)ACRYLIC POLYMER, AND METHOD FOR PRODUCING SAME Mitsubishi Chemical Corporation (JP) 2025-09-10 EP disclosed
EP-4613785-A1 ESTER-COMPOUND-CONTAINING COMPOSITION AND METHOD FOR PRODUCING SAME, POLYMERIZABLE COMPOSITION, AND (METH)ACRYLIC POLYMER AND METHOD FOR PRODUCING SAME Mitsubishi Chemical Corporation (JP) 2025-09-10 EP disclosed
EP-4610284-A1 MONOMER COMPOSITION, METHACRYLIC RESIN COMPOSITION AND PRODUCTION METHOD THEREFOR, AND MOLDED RESIN OBJECT Mitsubishi Chemical Corporation (JP) 2025-09-03 EP disclosed
US-20250250370-A1 METHACRYLATE-CONTAINING COMPOSITION, METHOD FOR PRODUCING METHACRYLIC ESTER, POLYMERIZABLE COMPOSITION, AND METHOD FOR PRODUCING METHACRYLIC ACID POLYMER MITSUBISHI CHEMICAL CORPORATION (JP) 2025-08-07 US disclosed
US-20250250221-A1 ESTER-COMPOUND-CONTAINING COMPOSITION AND METHOD FOR PRODUCING SAME, POLYMERIZABLE COMPOSITION, AND (METH)ACRYLIC POLYMER AND METHOD FOR PRODUCING SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2025-08-07 US disclosed
US-20250250376-A1 MONOMER COMPOSITION, METHACRYLIC RESIN COMPOSITION AND PRODUCTION METHOD THEREFOR, AND MOLDED RESIN OBJECT MITSUBISHI CHEMICAL CORPORATION (JP) 2025-08-07 US disclosed
US-20250250223-A1 ESTER COMPOUND-CONTAINING COMPOSITION, METHOD FOR PRODUCING SAME, POLYMERIZABLE COMPOSITION, (METH)ACRYLIC POLYMER, AND METHOD FOR PRODUCING SAME MITSUBISHI CHEMICAL CORPORATION (JP) 2025-08-07 US disclosed
EP-4592323-A1 ESTER-COMPOUND-CONTAINING COMPOSITION AND METHOD FOR PRODUCING SAME, METHODS FOR PRODUCING POLYMERIZABLE COMPOSITION AND (METH)ACRYLIC POLYMER Mitsubishi Chemical Corporation (JP) 2025-07-30 EP disclosed
US-20250236582-A1 ESTER-COMPOUND-CONTAINING COMPOSITION AND METHOD FOR PRODUCING SAME, POLYMERIZABLE COMPOSITION, AND METHOD FOR PRODUCING (METH)ACRYLIC POLYMER MITSUBISHI CHEMICAL CORPORATION (JP) 2025-07-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250250221-A1 ESTER-COMPOUND-CONTAINING COMPOSITION AND METHOD FOR PRODUCING SAME, POLYMERIZABLE COMPOSITION, AND (METH)ACRYLIC POLYMER AND METHOD FOR PRODUCING SAME ADCY6, ADCY5, AMD1 SIGMAR1 2937/4885CSNK1E 3652/4885HTR2A 3097/4885
US-20250236582-A1 ESTER-COMPOUND-CONTAINING COMPOSITION AND METHOD FOR PRODUCING SAME, POLYMERIZABLE COMPOSITION, AND METHOD FOR PRODUCING (METH)ACRYLIC POLYMER MCCC2, ASS1, MMAB SIGMAR1 1338/4885CSNK1E 4051/4885HTR2A 3735/4885
US-20250250370-A1 METHACRYLATE-CONTAINING COMPOSITION, METHOD FOR PRODUCING METHACRYLIC ESTER, POLYMERIZABLE COMPOSITION, AND METHOD FOR PRODUCING METHACRYLIC ACID POLYMER MMAB, MAT2B, MEP1B SIGMAR1 2841/4885CSNK1E 3101/4885HTR2A 838/4885
US-20250250223-A1 ESTER COMPOUND-CONTAINING COMPOSITION, METHOD FOR PRODUCING SAME, POLYMERIZABLE COMPOSITION, (METH)ACRYLIC POLYMER, AND METHOD FOR PRODUCING SAME MMAB, ADCY8, MAT1A SIGMAR1 4290/4885CSNK1E 4275/4885HTR2A 2968/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.